*ST金比(002762.SZ):正籌劃公司控制權變更事項 6月5日起停牌
格隆匯6月4日丨*ST金比(002762.SZ)公佈,公司近日收到控股股東、實際控制人林浩亮先生、林若文女士的通知,其正在籌劃公司股份協議轉讓事宜,具體方案尚待溝通確定。鑑於上述事項尚存在重大不確定性,為保證公平信息披露,維護投資者利益,避免造成公司股價異常波動,根據《深圳證券交易所股票上市規則》《深圳證券交易所上市公司自律監管指引第6號——停復牌》等有關規定,特向貴所申請,公司股票(股票簡稱:*ST金比,股票代碼:002762)自2025年6月5日(星期四)上午開市起停牌,預計停牌時間不超過2個交易日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.